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ABSTRACT 
Amyotrophic lateral sclerosis is neurodegenerative disease characterized by late-onset, 
loss of motor neurons, paralysis, and eventual death. SOD1 is a free radical scavenger that 
normally resides in the cytoplasm, nucleus, and intermembrane space of the mitochondria. 
Mutations in SOD1, a ubiquitously expressed free-radical scavenger, are one cause of ALS. 
Degeneration of motor neurons is thought to be triggered by aggregation of mutant SOD1 
followed by propagation to adjacent cells though cell-cell contacts. Here, we present 
immunohistochemical findings on tissues of a Drosophila melanogaster expressing mutant 
dsod1 alleles at the endogenous locus. Aggregate-specific antibodies were used to assess the 
presence of aggregates in salivary gland tissues and the CNS for mutant and wildtype sod1 
alleles. Immunocytochemistry revealed the presence of large cytoplasmic aggregates near the 
nuclei of larval salivary glands of dsod1G85R/G85R mutants and in the salivary glands and CNS of 
dsod1H48R/H48R mutants. Aggregation phenotypes occurred with partial penetrance and penetrance 
did not increase with age. Furthermore, because both dsod1G85R/G85R and dsod1H48R/H48R mutants 
exhibit lethal phenotypes with complete penetrance, our data suggest a lack of correlation 
between the presence of visible aggregates and toxicity.  
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AMYOTROPHIC LATERAL SCLEROSIS 
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease 
characterized by the loss of motor neurons, paralysis, and death (Haverkamp et al., 1995). The 
disease has a three to five-year prognosis, with <20% surviving five years after the initial 
symptoms (Grad et al., 2014). Ten percent of cases are familial (fALS) and the remaining 90% 
are sporadic (sALS), with unknown origin (Grad et al., 2014). Risk factors for sporadic ALS 
include environmental exposures such as BMAA exposure (Bradley & Mash, 2009), nutrition 
such as higher consumption of carbohydrates (Okamoto et al., 2007), and trauma such as 
repeated head injuries (Chen et al., 2007).  
In familial ALS (fALS), inheritance is mostly dominant and monogenic, following a 
Mendelian pattern of inheritance (Gros-Louis et al., 2006). Currently, >20 genes have been 
identified as causal and the function of these gene products fall into several classes (Chen et al., 
2013). Mutations in RNA processing genes consist of one subset of causal genes. This includes 
mutations in the ubiquitinated TAR DNA binding protein (TDP-43), which is normally involved 
in RNA splicing (Buratti & Baralle, 2001), gene transcription (Lalmansingh et al., 2011), 
microRNA processing and stabilization (Kawahara & Mieda-Sato, 2012), and mRNA transport 
(Chu et al., 2019). This also includes the RNA-binding protein FUS (Crozat et al., 1993) which 
is linked to ALS due to aberrant RNA processing. Moreover, mutations in genes that cause 
axonal transport dysfunction such as DCTN1, a motor protein responsible for ATP hydrolyzation 
coupled with cellular motility (Holzbaur & Tokito, 1995), causes some fALS cases. Mutations 
the integral ER membrane protein VAPB also causes some fALS cases (Münch et al., 2004; 
Nishimura et al., 2004) due to metabolic disturbance in vesicle trafficking (Nishimura et al., 
2004) and lipid transporting (Han et al., 2013).  
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The research surrounding other ALS-causing genes suggests disease can result from a 
variety of pathways involved in RNA processing, axonal transport, or metabolism for fALS; 
however, clear, unequivocal triggers that lead to sALS are still unknown. Much research 
therefore focuses on fALS in hopes that we will understand the underlying mechanisms of sALS, 
given the overlapping clinical features of the disease. fALS has been modeled in many 
genetically tractable systems using a variety of genetic engineering techniques to express 
pathogenic fALS alleles for almost all identified genes thus far. 
SOD1 
A large area of ALS-related research concerns superoxide dismutase 1 (SOD1) which can 
cause both fALS and sALS (Cudkowicz et al., 1997). While some SOD1 mutations do not cause 
fALS (Mayeux et al., 2003), there is potential for abnormal interactions between mutant SOD1 
and a pathway or with itself that can hinder it more susceptible to the development of the 
sporadic condition. Also, there is also the possibility that SOD1 mutations occur de novo without 
prior family history, resulting in the sporadic condition. Further SOD1 research may bridge the 
understanding between the familial and sporadic conditions. Disease alleles in SOD1 were first 
linked to ALS patients through work done by Rosen et al. (1993). In fALS, more than 170-point 
mutations in SOD1 (Sangwan et al., 2017) account for ~20% of all fALS cases (Pasinelli & 
Brown, 2006). Most of the disease-causing mutations of SOD1 are in exon coding regions, 
suggesting aberrant protein function rather than levels of expression are associated with disease. 
Superoxide dismutase 1 (SOD1) is a ubiquitously expressed homodimer and each subunit 
has copper and zinc atom binding sites. The SOD1 gene is also highly conserved across different 
species suggesting it has a crucial role in cellular function (Fridovich et al., 1995). In the cell, 
SOD1 converts superoxide anions to hydrogen peroxide, which is then converted to water and 
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oxygen enzymatically by catalase. This enzymatic activity is essential for reducing oxidative 
damage as a result of aerobic metabolism in cells. SOD1 is located within the cytoplasm, 
nucleus, and intermembrane space of the mitochondria to protect against oxidative damage 
(Sturtz et al., 2001), suggesting that loss of enzyme function consequently leads to oxidative 
stress.  
Gain or loss of function. Although the enzymatic activity of wildtype SOD1 plays a 
protective role against oxidative stress, research suggests that ALS-causing mutations result in 
misfolding of the enzyme creating a range of allele-specific enzymatic activity patterns.  
In the human disease, most SOD1 mutations are dominant, suggesting a gain of function which 
has been identified as the propensity of the protein to form toxic aggregates. Yet, there is a 
decrease in enzymatic activity for almost all mutant alleles, suggesting a loss of function. Based 
on red blood cell data from human ALS patients, 48 different SOD1 mutants showed an overall 
reduction of SOD1 activity that averaged 58% (Saccon et al., 2013). It is still debated whether 
mutated SOD1 results in a gain of function or loss of function disease. The consensus is that 
there is a gain of function component because all SOD1 fALS mouse models exhibit SOD1 
aggregation, while SOD1 knockout mice do not develop classical ALS, although they do show 
some motor neuron pathology (Reaume et al., 1996). These data could suggest that SOD1 is not 
essential to the development of motor neurons, but SOD1-deficiencies increases the likelihood of 
motor neuron injury over time (Reaume et al., 1996). Thus, some scientists believe that 
mutations in sod1 cause fALS by both a gain and loss of function. 
Animal Models of ALS  
It is critical that researchers have the appropriate disease model to study ALS. It is 
important for animal models to not only express disease alleles but that the phenotypes 
11 
 
recapitulate disease features. Specifically, for ALS, an animal model should display adult-onset, 
neurodegeneration, and lethality. Models of fALS can help determine whether SOD1 mutants are 
gain or loss of function alleles and whether that information can be translated to human 
therapeutics. If fALS caused by SOD1 mutations results from a loss of enzyme activity, free-
radical scavengers or antioxidant therapies may hold potential value in humans.  If the disease 
state results primarily from gain of function, then therapeutics which eliminate protein 
aggregates may hold potential value. Valid animal models can serve to assess the potential for 
new drugs. 
Over the years, researchers have developed different SOD1 models that phenotypically 
display ALS-related symptoms. To achieve the diseased state, researchers have developed 
transgenic models with the goal of reproducing ALS-associated phenotypes. Whereas human 
fALS follows a dominant monogenic pattern of inheritance, engineered mouse models rely on 
multiple copies of an inserted hSOD1 transgene to reproduce ALS-like phenotypes. This is true 
for both wildtype and mutant models. For example, one wildtype transgenic mouse expressed 
10.5 copies of the transgene (Wong et al., 1995). Overexpression of wildtype humanized SOD1 
has been shown to reproduce some disease features such as mitochondrial swelling in spinal cord 
axons, axonal degeneration, mild motor neuron death, and motor abnormalities (Jaarsma et al., 
2000). Similarly, mutant copy can vary from as much as 10 (Gurney et al., 1997) to 18 (Gurney 
et al., 1994) copies and this also negatively affects survival. With an increasing copy number of 
the G93A transgene from 4 to 34, survival went from 625.0 to 99.0 days (Alexander et al., 2004). 
Accelerated disease onset was also shown in mice overexpressing G85R (Wang et al., 2009). 
Although wildtype and mutant studies of overexpression have provided useful 
information about the mechanisms underlying ALS, it is unclear how relatable the results of 
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these transgenic mice models are to the human disease. Expression of endogenous mutant SOD1 
in fALS in humans leads to neurodegeneration while not requiring overexpression (Ferrera et al., 
2003). No model organism can mimic every aspect of the human disease, but most models do 
replicate one trademark of ALS seen in humans based on postmortem examination: protein 
aggregates. 
SOD1 Aggregates 
Protein aggregates are a characteristic hallmark of ALS pathology and are found in the 
spinal cord samples of fALS (Johnston et al., 2000; Gruzman et al., 2007) and sALS patients 
(Shibata et al., 1994). Researchers have developed various procedures to detect the presence of 
aggregates in cells, and specifically, to detect the presence of SOD1 in aggregates.  
Detecting Protein Aggregates. One method is size-exclusion chromatography, which separates 
molecules based on size using gel filtration (Martins & English, 2014).  This method effectively 
separates lower molecular weight soluble proteins from large molecular weight, insoluble 
aggregates. Another example comes from the quantification of aggregates formed by dose-
dependent protease inhibition (Lee et al., 2017). Detergent extractions can also be used to detect 
aggregates. In this procedure, protein is separated into soluble and insoluble fractions, where 
higher molecular aggregates will be present in the insoluble portion (Prudencio & Borchelt, 
2011). Also, fluorescent microscopy has been used to detect SOD1 fused to fluorescent proteins 
in cell culture or in vivo (Álvarez-Zaldiernas et al., 2016).  
As a related technique, antibodies which specifically recognize aggregated protein can be 
utilized. Immunoblotting with an anti-SOD1 antibodies has detected the presence of SOD1 
aggregates in various assays (Bruijn et al., 1997; Wang et al., 2009; Afshar et al., 2017). Bergh et 
al. (2015) developed polyclonal mono-specific antibodies that recognized specific residues on 
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wildtype and misfolded humanized SOD1 in mice. The researchers discovered that the antibody 
raised against the conformationally hidden 57-72 epitope recognized a misfolded state of human 
SOD1 when expressed in mouse models and in post-mortem tissue. The antibody raised against 
the 111-127 SOD1 epitope recognized a mostly hidden structure in the protein and was found to 
detect aggregates as well, although evidence suggests that this latter antibody recognizes a 
different misfolded state. Both epitopes are good antibody recognition candidates for the 
detection of misfolded SOD1 and suggest that the protein can take on multiple independent 
aggregate conformations. 
Formation of Misfolded SOD1 Inclusions. Properly detecting SOD1 in ALS models has 
provided and will continue to provide important information on the molecular and cellular 
behaviors of SOD1 under different conditions. Relevant to the present study, SOD1 aggregate 
detection and characterization can provide useful information regarding its role in disease. 
Evidence suggests that SOD1 can take on prion-like properties when misfolded. Prions are 
proteins with strong, covalently linked beta-pleated sheets which can propagate the misfolding of 
more protein (Pan et al., 1993). Prion diseases begin with a primary prion protein that interacts 
with other natively folded protein of the same kind to promote misfolding and beta-pleated sheet 
formation (Geschwind, 2015). Prions continue to convert more protein exponentially, 
accumulate, and can migrate between cells through release in the extra-cellular matrix and 
through gap junctions. It is unknown if the prion induces the accumulation or if some 
unidentified intermediate structure is responsible for promoting conversion (Geschwind, 2015).  
One route of protein misfolding and aggregation comes from post-translational studies of 
SOD1. Mutant and oxidized SOD1 also display the ability to sequester and promote aggregation 
(McAlary et al., 2016; Martins & English, 2014). The kinetics of post-translational modification 
14 
 
is critical to proper protein folding and maturation (Bruns & Kopito, 2007). This can include the 
binding of the zinc atom, which is suggested to be important for stabilization of the protein (Sea 
et al., 2015). Also, mutations in the copper binding region slow kinetic rates of dimerization and 
disulfide bond oxidation (Bruns & Kopito, 2007). Problems in post-translational modifications 
can therefore result in aberrant SOD1 protein. 
Destabilization of native SOD1 structure due to mutations such as A4V effected dimer 
interactions and subunit misfolding (Deng et al., 1993). Also, destabilization of the protein is 
associated with the ability to form aggregates and induce cell toxicity (McAlary et al., 2016). 
Mutant SOD1 can adopt several conformations that are more susceptible to aggregation and 
higher order filaments. As SOD1 misfolds, hydrogen bonds become more established between 
the beta strands and amyloid-like structures form as a direct result of mutated SOD1 (Banci et 
al., 2008). Similarly, metal-binding deficient human SOD1 misfolded to create filaments that 
interacted and promoted the assembly of higher order filaments (Elam et al., 2003).  
Aggregates are a common phenotype amongst post-mortem fALS (Johnston et al., 2000), 
sALS (Shibata et al., 1996; Paré et al., 2018), and mice ALS spinal cord samples (Bergh et al., 
2015). Mutations in other ALS-causing genes also produce protein aggregates (Neumann et al., 
2006; Deng et al., 2010; Deng et al., 2011). These high molecular weight inclusions consist of 
misfolded protein and their penetrance in causal-ALS suggests toxic properties, based on 
ubiquitination and autophagy activation. 
Aggregate toxicity. Exactly how aggregated proteins are toxic to cells is not yet fully 
understood. Ubiquitination is a part of a major degradation pathway called the ubiquitin 
proteasome system (Ramesh & Pandey, 2017) and ubiquitinated inclusions are present in both 
fALS and sALS (Leigh et al., 1991; Mather et al., 1993), which suggests the activation of this 
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degradation system. There was an accumulation of inclusions in the astrocytes of human G85R 
mice as the disease progressed, and these inclusions were immunoreactive for ubiquitin (Bruijn 
et al., 1997). Similar to mutants, oxidized wildtype SOD1 was poly-ubiquitinated (Ezzi et al., 
2007), therefore suggesting that degradation cascades are activated in the presence of mutant and 
oxidized wildtype SOD1. 
 Autophagy, which is another major protein degradation pathway, is also activated in ALS 
(Ramesh & Pandey, 2017). A common autophagy marker was used to detect the activation of 
autophagy degradation in transgenic SOD1G93A mice (Xie et al., 2015). Deficiencies in key 
players of the autophagy pathway result in early onset of ALS (Tokuda et al., 2016) and 
exacerbated aggregation (Nassif et al., 2014), indicating its crucial role in the removal of these 
toxic elements. The importance of autophagy was also demonstrated in a food restriction diets of 
mice (Zhang et al., 2013). Food restriction induced autophagy and when restriction was 
implemented at the onset of disease rather than at a later stage, it had a favorable impact on 
SOD1G93A mice. 
 Cells attempted to eliminate protein aggregates based on the induction of protein 
degradation pathways, but when cells are unsuccessful, the most evident consequence is death. 
For instance, cultured motor neurons that uptake SOD1-positive aggregates were selectively 
killed (Benkler et al., 2018). The formation of aggregates was associated with reduced cell 
survival in cells expressing mutant SOD1 (Matsumoto et al., 2005). Aggregates may be the result 
of unsuccessful protein degradation attempts, and therefore it is important to further characterize 
their role in disease.  
It is worth noting that high-molecular weight aggregates have catalytically inactive 
SOD1, whereas low-molecular weight aggregates have catalytically active SOD1 (Martins & 
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English, 2014), suggesting a toxic intermediate. The properties of soluble SOD1 intermediates 
correlate with the properties of toxic prion-like intermediates that propagate misfolding.  
SOD1 Prion-like Intermediate. SOD1 monomers have properties that can promote the 
formation of higher order structures. In vitro, oxidatively damaged wildtype and mutant SOD1 
dissociated into their monomers and slight changes to the secondary and tertiary structure of the 
protein promoted aggregation (Rakhit et al., 2004; Khare et al., 2004). The inactive monomer 
could be the intermediate that induces misfolding and aggregation. Similarly, SOD1 mutants 
with specifically exposed hydrophobic sequences have the potential to induce aggregation 
(Münch & Bertolotti, 2010).  
The activity of these toxic intermediates may be due to deficiencies in metal binding of 
SOD1. Reduced monomeric forms of mutant SOD1, which tend to have more prominent metal 
binding mutations, are more susceptible to oligomerization by the oxidization of free cysteines 
(Banci et al., 2007). Inadequate folding of SOD1 due to delays in post-translational folding 
kinetics can result in the failure to incorporate metal cofactors important for stability and 
function (Bruns & Kopito, 2007).  
These toxic intermediates result in aberrant behaviors. For example, SOD1 was found to 
only interact with a specific neurosecretory protein when mutated but the oxidized form also 
bound the protein, suggesting that oxidized SOD1 developed a mutant-like property (Ezzi et al., 
2007). Also, oxidized wildtype SOD1 induced inflammatory pathways in cultured motor neurons 
(Ezzi et al., 2007). 
While research points towards a toxic intermediate that mitigates aggregation, another 
prion-like property of SOD1 exits. Evidence suggests that like prions, SOD1 can be released to 
the surrounding environment and mitigate aggregation of proteins in other cells.  
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Extracellular vesicles. SOD1 displays the ability to spread itself intercellularly by extracellular 
vesicles (Grad et al., 2014). Evidence suggests that mutant SOD1 expressed in astrocytes had 
increased unconventional secretory pathways, which included the release of SOD1 by exosomes 
(Basso et al., 2013). The increased activity could be a protective response to decrease the amount 
of mutant protein in the cell, as an attempt to prevent aggregate formation. Moreover, wildtype 
and mutant SOD1 were secreted from motor neuron-like cells through exosomes (Gomes et al., 
2007).  
Research suggests that cells release aggregates into the extracellular environment through 
exosomes and it was observed that nearby healthy cells were infected (Fevrier et al., 2004), 
suggesting progressive spread. Hence, the release and spread of misfolded SOD1 from cell to 
cell by exosomes may explain how the sporadic condition progresses without the presence of a 
causal genetic component (Grad et al., 2014). Though misfolded SOD1 is observed in the 
inclusions of fALS models, the presence of SOD1 positive inclusions is still highly debated in 
the field.  
sALS and Aggregates. Determining whether protein aggregates are pathologic in sporadic cases 
of ALS is still unknown and debated. SOD1-containing inclusion have been extracted from 
SOD1-linked sALS patient spinal cord tissue, suggesting that the wildtype protein can exert 
similar effects as mutant SOD1 (Gruzman et al., 2007; Forsberg et al., 2010). While some 
research groups have evidence to suggests the presence of misfolded SOD1 in post-mortem 
sALS patients (Paré et al., 2018; Bosco et al., 2010; Forsberg et al., 2010), others find no 
evidence of misfolded SOD1 (Liu et al., 2009; Kerman et al., 2010) or find no difference 
between controls and sALS patients (Da Cruz et al., 2017).  
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One group found cytoplasmic misfolded SOD1 in the spinal cord of post-mortem sALS 
patients using four different polyclonal antibodies and one monoclonal antibody that recognized 
different epitopes of SOD1 and were also able to immunocapture misfolded SOD1 (Paré et al., 
2018). The immunohistochemical staining suggested that SOD1 can take on different 
conformations when misfolding. Paré and colleagues (2018) argued that differences in 
methodology such as antibody concentration or buffer choices may be the reasons why some 
researchers do not find misfolded SOD1 in sALS cases. Regardless of the debate, there are 
countless studies that have found SOD1-positive inclusion in human sALS spinal cords (Shibata 
et al., 1994; Matsumoto et al., 1996), suggesting that SOD1 plays a role in aggregate production 
or degradation.  
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INTRODUCTION 
Drosophila melanogaster as a model of ALS  
To understand the underlying roles of SOD1 in aggregate production, it is critical to use a 
proper model organism that displays the characteristics of the human disease. Though most of 
the ALS-model organism research comes from mice studies, there are downsides to this model. 
In mice, fALS is modeled by overexpressing mutant human sod1 alleles. This occurs in a genetic 
background containing endogenous wildtype SOD1 orthologs. Thus, the genetics of the mouse 
ALS model is quite different from the human state in which a single mutant allele is sufficient to 
produce disease phenotypes.    
Drosophila melanogaster was first used a model system in 1910 by the Morgan lab at 
Columbia University (Morgan, 1910). Since then, it has become a useful scientific tool to study 
the genetics of disease and neurodegeneration. Drosophila are also inexpensive to maintain, mate 
quickly, and have shorter lifespans than larger model systems. This allows for more and faster 
results. Drosophila genetics can be easily manipulated to express certain genes in a tissue-
specific or dosage-specific manner. Moreover, the entirely sequenced genome of Drosophila was 
available in 2000 (Adams et al., 2000), expanding the incite of genetic associations on disease.  
Drosophila has also been used as a model for other neurodegenerative diseases, such as 
Parkinson’s (Lee et al., 2007), tauopathies (Blard et al., 2007), and polyglutamine expansion 
diseases (Jackson et al., 1998). In the context of SOD1-ALS, Drosophila is a great organism to 
recapitulate the human disease, as they have a simpler nervous system and reproduce ALS-like 
phenotypes such as SOD1-positive aggregates (Bruijn et al., 1997), motor dysfunction (Held et 
al., 2019), mitochondrial dysfunction (Gallart-Palau et al., 2016), and decreased lifespan (Şahin 
et al., 2017).  
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Creating an ALS model by homologous recombination. To create a model which does not 
rely on SOD1 overexpression, Şahin and colleagues (2017) knocked in wildtype and mutant 
Drosophila sod1 (dsod1) into the endogenous locus of the Drosophila genome using ends-out 
homologous recombination. This fALS model successfully displayed typical human ALS 
phenotypes such as reduced lifespan and decreased motor function; however, all these 
phenotypes were recessive unlike the human disease. Interestingly, fly models containing 4 
copies of sod1 (sod1G85R/G85R; sod1+/+) show phenotypes similar to mouse models and are the 
closest to the mouse genotypes used to recreate disease features. 
Purpose of research. To detect dSOD1 aggregation in ALS, I used immunocytochemistry to 
visualize wildtype and mutant dSOD1 protein in the salivary glands and CNS of a Drosophila 
melanogaster model of ALS made by homologous recombination. These tissues were chosen 
because the salivary glands of larvae are useful to detecting protein due to their large cell size 
and polytene nuclei. Moreover, using adult tissue can be more beneficial at tracking disease 
progression with age. The CNS was used because ALS is a neurodegenerative disease and late-
stage phenotypes of fALS and sALS include protein aggregates in the spinal cord samples of 
patients (Gruzman et al., 2007). Therefore, evidence of mutant SOD1-positive aggregates in the 
Drosophila CNS would suggest that SOD1 accumulation is not unique to the human disease and 
strengthens the argument that SOD1 can play a role in aggregate formation. My results show that 
mutants dsod1G85R/G85R and dsod1H48R/H48R displayed mutant-specific aggregation phenotypes at 
partial penetrance in salivary glands which was not age-dependent and dsod1H48R/H48R VNC 
samples displayed large cytoplasmic aggregates that colocalized with the nucleus at partial 
penetrance. Also, smaller salivary glands and increase misfolded dSOD1 staining was caused by 
knockdown of ebp1, a known enhancer of heterozygous dsod1G85R/+ flies. These results suggest 
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that dSOD1 protein can adopt various conformations, and that aggregates do not completely 
correlate with lethality.  
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MATERIALS and METHODS 
Drosophila melanogaster stocks  
Ends-out homologous recombination (HR) was used to create the dsod1WTLoxP (dsod1+) 
dsod1G85R, dsod1H48R, and dsod1H71Y stocks as previously described (gift from the Reenan lab, 
Brown University) (Şahin et al., 2017). All mutant alleles were maintained as heterozygous 
stocks over 3rd chromosome balancers. CRISPR/Cas9 was used to create the dsod1-/- and 
hsod1m1m5 stocks as previously described (Şahin et al., 2017) and were maintained as 
heterozygous stocks over a 3rd chromosome balancer. The stocks were reared on standard 
Drosophila medium containing corn meal, yeast, and sucrose at 23˚C under 12hr light/dark 
cycles. 
WT and Aggregate Specific Antibodies  
Rabbit anti-dsod1 polyclonal antibodies were synthesized at Pacific Immunology. The antibodies 
were isolated, purified, resuspended in saline, after rabbits were inoculated with synthesized 
peptide sequences: CMSSGPHFNPYGKEHG for antibody 56-71, SIIGRTVVVHADADDL for 
antibody 111-126, and ADADDLGQGGHELSKSTGNAGAR for antibody 120-142. The 
respective antibodies were affinity purified from crude serum, resuspended in saline, and stored 
at -20 as frozen aliquots. 
Immunohistochemistry  
Drosophila tissues were dissected in 1x PBS and fixed in 3.4% formaldehyde (Salivary glands = 
25 min; adult brains and VNC = 30 mins) at room temperature. Samples were quickly washed 
three times in PBTx (1x PBS + 0.1% Triton-X) and then three 15-min washes. Samples were 
incubated in 5% normal goat serum in PBTx for at least 2 hours before being incubated in 
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primary antibody over-night (see figure captions for concentrations). Prior to use, the primary 
antibodies were pre-absorbed against tissue from dsod1null flies for 24 hrs to increase specificity.   
Following incubations with primary antibody, tissues were washed quickly three times in PBTx 
before three 15-min washes and incubated in secondary antibody AlexaFluor 488 or 649 (see 
figure captions for concentrations). Samples were washed quickly three times in PBTx before 
three 15-min washes and stained with DAPI in 1x PBS (1:1000). Three quick 1x PBS washes 
were conducted and samples were mounted in diamond mount. Slides were kept at 4 ˚C before 
imaging. 
Confocal Microscopy and Quantification of Fluorescence Using ImageJ 
Images were taken on an Olympus Fluoview 1000, utilizing an IX81 inverted confocal 
microscope. All fluorescent signals were captured within the linear detection range for 
quantification purposes. Imaging processing was performed in ImageJ (FIJI) and consisted of 
optimizing brightness and contrast for publication. Fluorescent signals were quantified using the 
Analyze à Set Measurements tab of ImageJ. Briefly, the region of interest (ROI) was designated 
using the ellipse tool and the integrated signal density of each ROI was determined using the 
Analyze à Measure function within ImageJ. Three measurements were taken for the cytoplasm 
and nucleus of cells. Three measurements were taken for the background, which is area outside 
of the sample, and the average was used to correct the background. The corrected total cell 
fluorescence, CTCF, was calculated for each measurement (equation based on Vlab Amrita Edu., 
2012). In this equation, the area of the circle was multiplied by the mean gray value of the 
background and the product was subtracted from the integrated density of the cytoplasmic or 
nuclear measurements to obtain CTCF values. CTCF values were averaged for the cytoplasmic 
and nuclear measurements of each sample for each larval line. 
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 ImageJ was used to collect vacuole lengths by using the line tool and measuring their 
lengths. The longest length within ten vacuoles for each sample were measured on ImageJ and 
further quantified on excel by averaging the ten measurements. ImageJ was also used to count 
the number of aggregates in an image. Images were converted to 16-bit and the pixel intensity 
threshold range was set to 65-65535. At this range, only aggregates were detected. Once applied, 
Process à Binary à Watershed unmerged any particles. Analyze à Analyze Particles produced 
the number of particles detected.  
Excel was used for statistics and graphs for all quantitative data collected using ImageJ.   
Compounds  
Mifepristone (Cayman Chemicals) was dissolved in DMSO.  
Enhancer Screen  
A genetic enhancer screen was conducted as described previously (Betancur, 2019).  To 
knockdown gene expression of ebp1 in sodG85R heterozygotes, males from line 34388 (y[1] sc[*] 
v[1] sev[21]; P{y[+t7.7] v[+1.8]=TRiP.HMS01382}attP2) obtained from the Bloomington Stock 
Center (https://bdsc.indiana.edu) were crossed to w-; tubulin-geneswitch Gal4, sod1G85R/Tm6Tb 
virgin females in standard fly food medium that contained 3µg/mL of mifepristone in 0.4% 
DMSO. After 7 days, adults were removed and wandering non-tubby larvae were collected for 
dissections.  
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RESULTS 
 A common characteristic among ALS-causing genes such as SOD1 is the presence of 
protein aggregates. To investigate the role of aggregates in ALS, we studied tissue samples from 
a Drosophila melanogaster model of ALS created by homologous recombination. Mutant 
Drosophila sod1 (dsod1) show recessive phenotypes including shortened lifespan, progressive 
axon loss and locomotion defects in contrast to the human disease state. We wanted to determine 
if short-lived phenotypes correlated with SOD1 protein aggregation. Using aggregate specific 
antibodies, we used immunohistochemical techniques to detect puncta. We used salivary glands 
because of their large cell size and pharate adult ventral nerve cords as a region of the CNS 
containing motor neuron cell populations.  
Assessing SOD1 aggregation using the 56-71 aggregate-specific antibody 
 To visualize aggregation status of dSOD1 protein, we stained salivary glands from 
dsod1+/+, dsod1H48R/H48R, and dsod1G85R/G85R wandering larvae using the aggregate specific 56-71 
antibody. This antibody specifically recognizes a hidden epitope on the native dSOD1 protein 
and therefore, fluorescent signals suggests misfolding protein. To first determine specificity of 
the antibody, we stained dsod1-/- animals which represent SOD1 protein nulls as controls. A 
representative single slice confocal image for dsod1-/- is shown in Fig. 1A. Here, we detected 
modest nuclear and cytoplasmic fluorescence which was quantified in Fig. 1B. This is 
attributable to background fluorescence or non-specific antibody binding. In contrast, salivary 
glands from wildtype animals displayed qualitatively higher nuclear staining that was 
comparable with the dsod1G85R/G85R mutants (Fig. 1A and 1B). dsod1H48R/H48R salivary gland 
staining showed lower nuclear dSOD1 levels than nulls (Fig. 1B). dsod1H48R/H48R salivary glands 
also displayed large and scattered cytoplasmic aggregates with partial penetrance (Fig. 1A and 
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Table 1). Aggregates are identified qualitatively as bright, localized punctae and represent a 
standard method for identifying aggregates (Gill et al., 2018). Large dSOD1-positive 
cytoplasmic aggregates were also detected near the nuclei of dsod1G85R/G85R samples at low 
penetrance (white arrows) (Fig. 1A; Table 1). Therefore, wandering dsod1H48R/H48R and 
dsod1G85R/G85R salivary glands display slightly different mutant-specific phenotypes with partial 
penetrance. 
Assessing SOD1 aggregation using the aggregate specific antibody 111-126 
 To further characterize dSOD1 aggregates, we stained salivary gland tissue with the other 
dSOD1 aggregate-specific antibody 111-126, which putatively recognizes a separate epitope that 
is mostly hidden in native dSOD1. We stained wandering dsod1-/-, dsod1+/+, and dsod1H48R/H48R 
salivary glands and representative images are shown in Fig. 2. The dsod1-/- negative control 
glands displayed similar background to dsod1+/+; however, salivary glands from dsod1H48R/H48R 
displayed a modest increase in nuclear and cytoplasmic staining compared to dsod1-/-. When 
present, most punctae in dsod1H48R/H48R salivary gland samples were small (~1-5 microns) though 
a small subset of samples displayed the large cytoplasmic aggregates as shown in dsod1H48R/H48R 
of approximately 5-10 microns as shown sample (B). These punctae were clearly distinct from 
any staining observed in null controls or wildtype (Fig. 2A and Table 1). This antibody revealed 
similar staining to that observed with the 56-71 antibody for dsod1H48R/H48R. Also, the 
dsod1H48R/H48R (B) sample displayed nuclear staining levels lower than what was observed in 
nulls (Fig. 2B). Together these results provide confidence that both antibodies identify as least 
some aggregate conformations. To quantify the number of aggregates across all lines, we used 
ImageJ software to detect aggregates over a specific pixel intensity threshold. We found the 
dsod1H48R/H48R (B) mutant samples showed binary aggregation status. Samples either had many 
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punctae (almost 2x more inclusions), or more commonly, we found dsod1H48R/H48R glands with 
relatively fewer inclusions (Fig. 2C). Therefore, wandering dsod1H48R/H48R salivary glands display 
a mutant-specific phenotype that was detected using two different aggregate-specific antibodies 
but with partial penetrance. This suggests a mutant-specific phenotype in which misfolded 
dsod1H48R/H48R is prone to aggregation in some individuals more than others. 
Time course analysis of dsod1H48R/H48R and dsod1G85R/G85R salivary glands 
 The fact that aggregation was not fully penetrant despite controlling for genotype was an 
intriguing finding. One possibility was that aggregation (seen most prominently in 
dsod1H48R/H48R) could be developmentally regulated and thus partial penetrance resulted from 
slightly different stages being used for each experiment. Salivary glands are larval specific 
tissues which undergo histolysis during the early stages of metamorphosis (Farkaš et al., 2015). 
Salivary gland cells undergo apoptotic and autophagic cell death in response to increased titers in 
the hormone 20-hydroxyecdysone in the absence of juvenile hormone. During histolysis, these 
cells undergo a number of molecular and morphology changes. To determine if dSOD1 protein 
localization and/or aggregation changes during development, we stained salivary glands 
dissected from animals over a time-course that spans the early stages of metamorphosis. While 
we observed no striking differences in phenotypes in mutants compared to wildtype for salivary 
glands of third-instar or wandering larvae, we found striking differences in salivary glands of 
mutant sod animals during the prepupal stages (Fig. 3). Specifically, we found that staining of 
dsod1+/+ and dsod1H48R/H48R salivary glands at pre-pupation with either of the aggregate specific 
antibodies resulted in coagulated dSOD1 under high magnification (Fig. 3). While we observed 
nuclear staining in dsod1+/+ at pre-pupation, generally, most samples displayed slightly more 
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nuclear staining in dsod1H48R/H48R nuclei (not shown). This observation was true using both 
antibodies.  
We took the time course analysis a step further by analyzing dSOD1 staining using the 
111-126 aggregate-specific antibody on dsod1-/-, dsod1+/+, dsod1G85R/G85R, and dsod1H48R/H48R 
salivary glands at pre-pupation and 8 hours post-pupation (Fig. 4). All lines at pre-pupation 
showed irregularly shaped cells and small cellular vacuoles likely linked to the initial stages of 
histolysis (Fig. 4A). Generally, null samples had the greatest number of smaller vacuoles when 
compared to the other lines (Fig. 4A). When comparing the pre-pupation and 8 hours post-
pupation salivary glands, the 8-hour samples were thinner than the pre-pupation samples (Fig. 
4A and 4B). Mutant dsod1H48R/H48R generally had more nuclear staining and nuclear envelope 
staining when compared to null and wildtype at pre-pupation (Fig. 4A). We observed that mutant 
lines generally looked comparable to wildtype at 8 hours post-pupation (Fig. 4B). Some 8 hours 
post-pupation samples from these lines displayed large vacuoles (Fig. 5A). The longest length 
from 10 vacuoles were analyzed using ImageJ tools and the lengths were averaged on excel. The 
null sample had the largest average length vacuoles compared to the wildtype, dsod1G85R/G85R, 
and dsod1H48R/H48R salivary glands (Fig. 5B). The dsod1G85R/G85R sample had the smallest average 
vacuole length when compared to the other lines.  
Assessing aggregation in adult VNCs 
 ALS is an adult-onset, neurodegenerative disease and therefore, it is important to 
characterize dSOD1 protein staining in the Drosophila nervous system. To further characterize 
dSOD1 protein staining in adult nervous tissue, we collected the ventral nerve cords (VNCs) of 
dsod1-/-, dsod1+/+, dsod1G85R/G85R, and dsod1H48R/H48R pharate adults (Fig. 7). We stained the 
VNCs with aggregate specific antibody 56-71 and visualized the results by confocal microscopy. 
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We found that both dsod1G85R/G85R and dsod1H48R/H48R VNCs displayed mutant-specific 
differences when compared to wildtype and null. Mutant dsod1G85R/G85R VNC displayed dense 
staining at high magnification compared to dsod1-/- and dsod1+/+ samples. The dsod1H48R/H48R 
VNC at high magnification displayed colocalization of dSOD1-positive aggregates with large 
nuclei. These large nuclei are consistent with motor neurons or glia though we never verified 
this. We saw that this colocalization in this specific area was observed in lower layers of the 
VNC (not shown). Similar to salivary glands, we observed this aggregation in a minority of 
cases. Therefore, VNC mutants display an aggregation phenotype in adult CNS with partial 
penetrance.  
Quantifying the partial penetrance of aggregation phenotypes. 
 As mentioned, immunohistochemistry of salivary glands revealed that while some mutant 
samples were comparable with null and wildtype, other samples displayed striking mutant-
specific cellular puncta. To quantify the percentage of glands containing these aggregates, we 
tallied samples containing large cytoplasmic aggregates. We kept track of the total number of 
samples for each dsod1 line under a specific antibody. For each line and antibody used, we 
divided the number of samples that had aggregates over the total for that subset. We found that 
no large cytoplasmic aggregates were found in dsod1+/+ salivary glands (Table 1). We also found 
that for dsod1G85R/G85R and dsod1H48R/H48R samples, the large cytoplasmic aggregates phenotype 
was partially penetrant (<16%) for all aggregate-specific antibodies (Table 1).  
Enhancing effects of Ebp1 knockdown in a heterozygous dsod1G85R background  
 Our previous research showed that knockdown of ErbB3-binding protein-1 (ebp1) caused 
selective lethality in dsod1G84R/+ heterozygotes compared to dsod1+/+ animals (Betancur, 2019). 
To determine whether knockdown of ebp1 knockdown affects SOD1 protein aggregation or 
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localization, we stained salivary glands from dsod1G85R/+ heterozygotes with and without 
knockdown of ebp1. Knockdown of ebp1 expression was achieved using dicer-mediated RNA 
interference (RNAi). A mifepristone (MIF)-sensitive Gal4 was used to drive expression of the 
UAS-RNAi construct, resulting in presumptive knockdown of ebp1 in the presence of MIF. 
Larvae were fed MIF in the food medium during development and we stained salivary glands 
from wandering larvae across genotypes in 3 ug/mL MIF food versus controls containing 0 MIF. 
Salivary glands were stained with aggregate-specific 56-71 and visualized by confocal 
microscopy (Fig. 8A). At 0μL/mL MIF, dSOD1 expression was comparable between all the lines 
(Fig. 8A and 8B). At 3µL/mL, the ebp1RNAi;dsod1G85R/+ salivary gland was much thinner in width  
compared to 0µL/mL treatments. Under ebp1 knockdown conditions, the average nuclear and 
cytoplasmic CTCFs were also higher for dSOD1 staining compared to 0 ul/mL MIF treatments 
(Fig. 8A and 8B). Thus, knockdown of ebp1 results in higher levels of misfolded SOD1 using 
the aggregate specific 56-71 antibody. Interestingly, while overall signal was increased, we 
found an absence of large punctae as described previously. Furthermore, the knockdown of ebp1 
in dsod1G85R/+ heterozygotes resulted in smaller salivary glands, though it is unknown if this is 
due to knock down of ebp1 alone. Future experiments will test the 56-71 antibody on the salivary 
glands of ebp1RNAi;dsod1+/+ to see if small glands are observed or if there is increased misfolded 
dSOD1 detected. Antibody staining data from dsod1-/- and dsod1G85R/+ at 3µL/mL should be also 
be included. 
 
DISCUSSION 
 In the present study, we analyzed SOD1 protein expression using antibody staining in 
SOD1 null, wildtype, and mutant tissues of a Drosophila ALS-model expressing dsod1 at 
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endogenous levels. We used conformationally-specific antibodies to detect dSOD1 in the cells of 
salivary glands, VNCs, and adult brains. Based on known SOD1 misfolding conformations in 
mammalian species, these antibodies recognize domains which are inaccessible for properly 
folded wildtype SOD1. It is unknown if the folding dynamics of SOD1 are the same in both 
Drosophila and the well characterized mouse models. Using antibodies 56-71 and 111-126, we 
detected SOD1 aggregation in dsod1G85R/G85R and dsod1H48R/H48R salivary glands at partial 
penetrance. Therefore, conformation-specific antibodies detected dsod1 mutant-allele-specific 
phenotypes in a Drosophila ALS model. Aggregates were also observed in VNCs with partial 
penetrance. Furthermore, as a previously identified enhancer of lethality, knockdown of ebp1 
induced dramatic morphological changes in salivary glands and increased amount of misfolded 
dSOD1.  
Aggregate-specific antibodies were engineered to detect misfolded dSOD1  
 Bergh and colleagues (2015) engineered SOD1 antibodies that recognized specific amino 
acid sequences on humanized SOD1. From this study, one antibody (56-71) recognized a 
conformationally hidden region that was detected by immunostaining with misfolded mutant 
hSOD1. Another epitope on the SOD1 protein correlates with a partially exposed on the native 
structure (111-126), and therefore can also be used to detect misfolded SOD1. These two regions 
inspired us to create similar antibodies that can detect misfolded conformations of Drosophila 
SOD1. 
Aggregate-specific antibodies detects mutant-specific phenotypes 
Aggregates are a common phenotype in fALS (Johnston et al., 2000; Gruzman et al., 
2007). We wanted to test our aggregate-specific antibodies in the salivary glands and VNCs of 
Drosophila expressing mutant alleles to reported molecular differences between control and 
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mutant lines, and more importantly, assess the presence of dSOD1-positive aggregates. While all 
dsod1-/- samples exhibited high background when using both antibodies,  dsod1+/+, 
dsod1G85R/G85R, and dsod1H48R/H48R samples generally exhibited enhanced staining in the nucleus 
and cytoplasm and we observed the presence of puntae, inferred to be aggregated protein. The 
fact that high background could be sometimes observed in sodnull, could be due to insufficient 
washing during the immunohistochemical protocol, incomplete blocking, or non-optimized 
antibody concentrations. One focus of future experiments should be to optimize the 
immunohistochemical procedure.  
We found that both aggregate-specific antibodies detected the same mutant-specific 
phenotypes with partial penetrance in dsod1G85R/G85R and dsod1H48R/H48R salivary glands (Fig. 1, 
Fig 2, and Table 1). dsod1G85R/G85R salivary glands displayed large cytoplasmic aggregates near 
the nucleus of cells, a phenotype not seen in wildtype samples (Fig.1 and Table 1). This may 
suggest that mutant dsod1G85R/G85R follows a pathological pathway leading to its interaction with 
structures near the nucleus, such as the endoplasmic reticulum (ER). Research suggests SOD1 
colocalizes to the ER under ER stress (Atkin et al., 2014; Medinas et al., 2018). It is possible that 
the ER fails to properly fold mutant dsod1G85R/G85R and the protein becomes stuck within the 
structure.  Further directions should determine how to induce this phenotype and determine 
whether there is colocalization between dsod1G85R/G85R protein and the ER in salivary glands.  
We also observed large cytoplasmic aggregates in dsod1H48R/H48R salivary glands with 
partial penetrance using both aggregate specific antibodies (Fig. 2 and Table 1). This phenotype 
was not observed in null or wildtype samples (Table 1). The amount of aggregates observed in 
the dsod1H48R/H48R sample far exceeded the amount found in the other dsod1 lines (Fig. 2B). 
Although most dsod1H48R/H48R salivary glands did not display this striking feature, the partial 
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penetrance of this phenotype suggests that dsod1H48R/H48R protein can induce the formation of 
large aggregates. Large dsod1-positive aggregates were detected in each cell of the salivary 
gland which also suggests that misfolded dsod1H48R/H48R has the prion-like property of 
propagating aggregation. It is possible that the aggregates arose in one cell and spread, or it is 
possible that the aggregates arose in every cell independently. Further experiments should 
explore what factors induce this phenotype and why it is specific to dsod1H48R/H48R salivary 
glands.  
Adult dsod1H48R/H48R flies also displayed a mutant-specific phenotype in the CNS. 
Interestingly, large nuclei colocalized with dsod1-positive aggregates in the VNCs of 
dsod1H48R/H48R pharate adults (Fig. 7). This phenotype was not observed in null or wildtype 
VNCs. It is unusual for aggregates to colocalize in the nucleus, but research suggests that SOD1 
can migrate to the nucleus under oxidative stress as a nuclear transcription factor (Tsang et al., 
2014).  
The ability to recapitulate aggregation in neuronal and non-neuronal tissues of a mutant 
Drosophila ALS model is an important observation and suggests the Drosophila knock-in model 
shares much overlap with mammalian overexpression models.  
From our study, we detected aggregates with partial penetrance. While only a fraction of 
samples analyzed showed aggregate formation, there is still 100% lethality for dsod1G85R/G85R and 
dsod1H48R/H48R. This result suggests that there is not a complete correlation between the presence 
of large, insoluble cytoplasmic aggregates and lethality. Based on studies in mammalian models, 
large dSOD1 aggregates are catalytically inactive (Martins & English, 2014) and are the product 
of the accumulation of aberrantly behaved dSOD1 protein. Our antibodies may be detecting 
small, misfolded mutant dSOD1 that is too small to be detected using confocal microscopy or 
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aggregates which are still soluble. For a number of misfolded proteins, intermediate forms  are 
highly reactive, have greater toxicity, and can induce misfolding of more protein to create higher 
order structures (Elam et al., 2003; Rakhit et al., 2004; Khare et al., 2004; McAlary et al., 2016). 
Therefore, if we are limited to detecting large aggregates using these antibodies, we may miss 
dSOD1 soluble intermediates responsible for disease lethality. 
Time course analysis and salivary gland histolysis 
 Due to the appearance of mutant-specific phenotypes, we conducted salivary gland time 
course analyses to determine whether the phenotypes were age-dependent. We believe the 
partially penetrant mutant phenotypes are not age-dependent because no result suggested the 
appearance of aggregates prior to histological events. Evidence of the large cytoplasmic 
aggregates present in dsod1G85R/G85R or dsod1H48R/H48R salivary glands from figures 1 or 2 were 
not detected throughout the time course analysis. Therefore, other factors such as cellular stress 
may be involved in the development of the mutant-specific phenotypes of dsod1G85R/G85R and 
dsod1H48R/H48R salivary glands.  
Ebp1 knockdown enhanced heterozygous dsod1G85R/+ disease phenotypes  
 ErbB3-binding protein 1 (ebp1) is a known enhancer of lethality in heterozygous 
dsod1G85R/+ larvae. Ebp1 is an RNA-bind protein involved in growth regulation, ribosome 
assembly, and rRNA processing (NCBI, 2020). Most ebp1 information comes from cancer 
research because of its involvement in the cell cycle (Hwang et al., 2016; Nguyen et al., 2016). 
Knockdown of epb1 alone in Drosophila larvae development followed Mendelian patterns of 
inheritance (refer to Betancur, 2019). Our results showed that when ebp1 is knocked down in the 
heterozygous dsod1G85R/+ background, we observed reduced salivary gland width when 
compared to controls and increased misfolded dSOD1 in the nucleus and cytoplasm of cells. We 
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did not stain epb1RNAi;dsod1+/+ salivary glands to determine whether the knockdown of ebp1 
alone results in reduced salivary gland size. Ebp1-/- expressing mice were ~30% smaller than the 
wildtype stains (Zhang et al., 2008). Due to the role of ebp1 in the cell cycle, it makes sense that 
a common phenotype of ebp1 knockdown is reduce animal size. Moreover, one study suggested 
that decreased expression of a cell cycle regulated protein in SOD1G85R mutant cells induced 
DNA damage and decreased viability (Wang et al., 2019). Therefore, irregularities in the 
involvement of ebp1 in growth regulation may result in cellular stress, which produced increased 
misfolded SOD1. Further testing is needed to recapitulate the results of the ebp1 enhancer screen 
and to determine how epb1 knockdown enhances heterozygous dsod1G85R/+ misfolding.  
ALS is a complex disease with various components that come together to induce 
pathological phenotypes. The present study has revealed mutant-specific phenotypes that may 
explain possible pathways involved in SOD1-ALS pathology. Although my research contributes 
few findings, these results can be built upon to further characterize protein expression of specific 
dsod1 disease-alleles in cells. The results can be correlated to the human disease to generate new 
therapeutics and treatments.  
 
 
 
 
 
 
 
 
37 
 
REFERENCES 
Adams, M.D., Celniker, S.E., Holt, R.A., Evans, C.A., Gocayne, J.D., Amanatides, P.G., … &  
Venter, J.C. (2000). The genome sequence of Drosophila melanogaster. Science,  
287(5461), 2185-2195. doi: 10.1126/science.287.5461.2185 
Alexander, G.M., Erwin, K.L., Byers, N., Deitch, J.S., Augelli, B.J., Blankenhorn, E.P., … &  
Heiman-Patterson, T.D. (2004). Effect of transgene copy number on survival in the G93A  
SOD1 transgenic mouse model of ALS. Molecular Brain Research, 130(1-2), 7-15. doi:  
10.1016/j.molbrainres.2004.07.002 
Álvarez-Zaldiernas, C., Lu, J., Zheng, Y., Yang, H., Blasi, J., Solsona, C., & Holmgren, A.  
(2016). Cellular redox systems impact the aggregation of Cu,Zn superoxide dismutase  
linked to familial amyotrophic lateral sclerosis. The Journal of Biological Chemistry,  
291(33), 17197-17208. doi: 10.1074/jbc.M115.708230  
Atkin, J.D., Farg, M.A., Soo, K.Y., Walker, A.K., Halloran, M., Turner, B.J., … & Horne, M.K.  
(2014). Mutant SOD1 inhibits ER-Golgi transport in amyotrophic lateral sclerosis.  
Journal of neurochemistry, 129(1), 190-204. doi: 10.1111/jnc.12493 
Banci. L., Bertini, I., Boca, M., Girotto, S., Martinelli, M., Valentine, J.S., & Vieru, M. (2008).  
SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization. PLOS, 3(2),  
e1677. doi: 10.1371/journal.pone.0001677 
Banci, L., Bertini, I., Durazo, A., Girotto, S., Gralla, E.B., Martinelli, M., … & Whitelegge, J.P.  
(2007). Metal-free superoxide dismutase forms soluble oligomers under physiological  
conditions: a possible general mechanism for familial ALS. PNAS, 104(27), 11263- 
11267. doi: 10.1073/pnas.0704307104 
Basso, M., Pozzi, S., Tortarolo, M., Fiordaliso, F., Bisighini, C., Pasetto, L., … Bonetto, V.  
38 
 
(2013). Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion  
pathway alterations and exosome release in astrocytes: implications for disease spreading  
and motor neuron pathology in amyotrophic lateral sclerosis. The Journal of biological  
chemistry, 288(22), 15699–15711. doi:10.1074/jbc.M112.425066 
Benkler, C., O’Neil, A.L., Slepian, S., Qian, F., Weinreb, P.H., & Rubin, L.L. (2018).  
Aggregated SOD1 causes selective death of cultured human motor neurons. Scientific  
Reports, 8, 16393. doi: 10.1038/s41598-018-34759-z  
Betancur, J. (2019). A forward genetic screen identifying lethal enhancers in a Drosophila  
melanogaster model of amyotrophic lateral sclerosis [Unpublished bachelor’s thesis].  
Rhode Island College.  
Blard, O., Feuillette, S., Bou, J., Chaumette, B., Frébourg, T., Campion, D., & Lecourtois, M.  
(2007). Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in  
Drosophila. Humans molecular genetics, 16(5), 555-56. doi: 10.1093/hmg/ddm011  
Bosco, D.A., Morfini, G., Karabacak, N.M., Song, Y., Gros-Louis, F., Pasinelli, P., … & Brown,  
R.H. (2010). Wild-type mutant SOD1 share an aberrant conformation and a common  
pathogenic pathway in ALS. Nature Neuroscience, 13(11), 1396-1403. doi:  
10.1038/nn.2660  
Bradley, W.G., & Mash, D.C. (2009). Beyond Guam: the cyanobacteria/BMAA hypothesis of  
the cause of ALS and other neurodegenerative diseases. Amyotrophic lateral sclerosis¸ 2,  
7-20. doi: 10.3109/17482960903286009  
Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A., Copeland, N.G., … &  
Cleveland, D.W. (1997). ALS-lined SOD1 mutant G85R mediates damage to astrocytes  
and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron,  
39 
 
18(2), 327-338. doi: 10.1016/s0896-6273(00)80272-x 
Bruns, C.K., & Kopito R.R. (2007). Impaired post-translational folding of familial ALS-linked  
Cu, Zn superoxide dismutase mutants. The Embo Journal, 26(3), 855-866. doi:  
10.1038/sj.emboj.7601528.  
Buratti, E., & Baralle, F.E. (2001). Characterization and functional implications of the RNA  
binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.  
Journal of Biological Chemistry, 276(39), 36337-36343. doi: 10.1074/jbc.M104236200 
Chen, H., Marie, R., Sandler, D.P., Umbach, D.M., & Kamel, F. (2007). Head injury and  
amyotrophic lateral sclerosis. American journal of epidemiology, 166(7), 810-816. doi:  
10.1093/aje/kwm153 
Chen, S., Sayana, P., Zhang, X., & Le, W. (2013). Genetics of amyotrophic lateral sclerosis: an  
update. Molecular Neurodegeneration, 8(28). doi: 10.1186/1750-1326-8-28 
Chu, J.F., Majumder, P., Chatterjee, B., Huang, S.L., & Shen, C.K. (2019). TDP-43 regulates  
coupled dendritic mRNA transport-translation processes in co-operation with FMRP and  
Staufen1. Cell Reports, 29(10), 3118-3133. doi: 10.1016/j.celrep.2019.10.061  
Crozat, A., Aman, P., Mandahl, N., & Ron, D. (1993). Fusion of CHOP to a novel RNA-binding  
protein in human myxoid liposarcoma. Nature, 363(6430), 640-644. doi:  
10.1038/363640a0 
Cudkowicz, M.E., McKenna-Yasek, D., Sapp, P.E., Chin, W., Geller, B., Hayden, D.L., …  
Brown, R.H. (1997). Epidemiology of mutations in superoxide dismutase in amyotrophic  
lateral sclerosis. Annals of neurology, 41(2), 210-221. doi: 10.1002/ana.410410212 
Da Cruz, S., Bui, A., Saberi, S., Lee, S.K., Stauffer, J., McAlonis-Downes, M., … & Ravits, J.  
(2017). Misfolded SOD1 is not a primary component of sporadic ALS. Acta  
40 
 
Neuropathologica, 134(1), 97-111. doi: 10.1007/s00401-017-1688-8 
Deng, H.X., Bigio, E.H., Zhai, H., Fecto, F., Ajroud, K., Shi, Y., … & Siddique, T. (2011).  
Differential involvement of optineurin in amyotrophic lateral sclerisis with or without  
SOD1 mutations. Archives of neurology, 68(8), 1057-1061. doi:  
10.1001/archneurol.2011.178 
Deng, H.X., Hentati, A., Tainer, J.A., Iqbal, Z., Cayabyab, A., Hung, W.Y., … & Siddique, T.  
(1993). Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide  
dismutase. Science, 261(5124), 1047-1051. DOI: 10.1126/science.8351519 
Deng, H.X., Zhai, H., Bigio, E.H., Yan, J., Fecto, F., Ajroud, K., … & Siddique, T. (2010). Fus- 
immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial  
amyotrophic lateral sclerosis. Annals of neurology, 67(6), 739-748. doi: 
10.1002/ana.22051  
Elam, J.S., Taylor, A.B., Strange, R., Antonyuk, S., Doucette, P.A., Rodriguez, J.A., … & Hart,  
P.J. (2003). Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant  
proteins linked to familial ALS. Nature Structural Biology, 10(6), 461-467. doi:  
10.1038/nsb935 
Ezzi, S.A., Urushitani, M., & Julien, J.P. (2007). Wild-type superoxide dismutase acquires  
binding and toxic properties of ALS-linked mutant forms through oxidation. Journal of  
Neurochemistry, 102(1), 170-178. doi: 10.1111/j.1471-4159.2007.04531.x 
Farkaš, R., Beňová-Liszeková, D., Mentelová, L., Mahmood, S., Ďatková, Z., Beňo, M., … &  
Mechler, B.M. (2015) Vacuole dynamics in the salivary glands of Drosophila  
melanogaster during prepupal development. Development, Growth & Differentiation, 57,  
74-96. doi: 10.1111/dgd.12193 
41 
 
Ferrera, L., Caponnetto, C., Marini, V., Rizzi, D., Bordo, D., Penco, S., … & Garre, C. (2003).  
An Italian dominant FALS Leu144Phe SOD1 mutation: genotype-phenotype correlation.  
Amyotrophic Lateral Sclerosis And Other Neuron Disorders, 4(3), 167-170. doi:  
10.1080/aml.4.3.167.170 
Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., … & Raposo, G. (2004).  
Cells release prions in association with exosomes. Proceedings of the National Academy  
of Sciences of the United States of America, 101(26), 9683–9688.  
doi:10.1073/pnas.0308413101 
Fridovich, I. (1995). Superoxide radical and superoxide dismutase. Annual review of  
biochemistry, 64, 97-112. doi: 10.1146/annurev.bi.64.070195.000525  
Gallart-Palau, X., Ng, C.H., Ribera, J., Sze, S.K., & Lim, K.L. (2016). Drosophila expressing  
human SOD1 successfully recapitulates mitochondrial phenotypic features of familial  
amyotrophic lateral sclerosis. Neuroscience letters, 624, 47-52. doi:  
10.1016/j.neulet.2016.05.006 
Geschwind M. D. (2015). Prion Diseases. Continuum (Minneapolis, Minn.), 21(6  
Neuroinfectious Disease), 1612–1638. doi:10.1212/CON.0000000000000251 
Gill, C., Phelan, J.P., Hatzipetros, T., Kidd, J.D., Tassinari, V.R., Levine, B., … & Vieira, F.G.  
(2018). SOD1-positive aggregate accumulation in the CNS predicts slower disease  
progression and increased longevity in a mutant SOD1 mouse model of ALS. Scientific 
Reports, 9, 6724. doi: 10.1038/s41598-019-43164-z 
Gomes C., Keller S., Altevogt P., & Costa J. (2007). Evidence for secretion of Cu,Zn superoxide  
dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neuroscience  
Letters, 428, 43-6. doi.org/10.1016/j.neulet.2007.09.024 
42 
 
Grad, L. I., Pokrishevsky, E., Silverman, J. M., & Cashman, N. R. (2014). Exosome-dependent  
and independent mechanisms are involved in prion-like transmission of propagated  
Cu/Zn superoxide dismutase misfolding. Prion, 8(5), 331–335.  
doi: 10.4161/19336896.2014.983398 
Grad, L.I., Yerbury, J.J., Turner, B.J., Guest, W.C., Pokrishevsky, E., O’Neill, M.A., … &  
Cashman, N.R. (2014). Intracellular propagated misfolded of wild-type Cu/Zn superoxide  
dismutase occurs via exosome-dependent and -independent mechanisms. PNAS, 111(9),  
3620-3625. doi: 10.1073/pnas.1312245111 
Gros-Louis, F., Gaspar, C., & Rouleau, G.A. (2006). Genetics of familial and sporadic  
amyotrophic lateral sclerosis. Biochimica et Biophysica Acta, 1762(11), 956-972. doi:  
10.1016/j.bbadis.2006.01.004 
Gruzman, A., Wood, W.L., Alpert, E., Prasad, M.D., Miller, R.G., Rothstein, J.D., … & Liu, J.  
(2007). Common molecular signature in SOD1 for both sporadic and familial  
amyotrophic lateral sclerosis. PNAS, 104(30), 12524-12529. doi:  
10.1073/pnas.0705044104 
Gurney, M.E. (1997). The use of transgenic mouse models of amyotrophic lateral sclerosis in  
preclinical drug studies. Journal of Neurological Sciences, 152, S67-73. doi:  
10.1016/s0022-510x(97)00247-5 
Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto. M.C., Polchow, C.Y., Alexander, D.D., … &  
Siddique, T. (1994). Motor neuron degeneration in mice that express human Cu,Zn  
superoxide dismutase mutation. Science, 264(5166), 1772-1775. doi:  
10.1126/science.8209258 
Han, S.M., Oussini, H.E., Scekic-Zahirovic, J., Vibbert, J., Cottee, P., Prasain, J.K., … & Miller,  
43 
 
M.A. (2013). VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism  
critical for adult survival in Caenorhabditis elegans. PLOS Genetics, 9(9), e1003738.  
doi: 10.1371/journal.pgen.1003738 
Haverkamp, L.J., Appel, V.A., & Appel, S.H. (1995). Natural history of amyotrophic lateral  
sclerosis in a database population: Validation of a scoring system and a model for  
survival prediction. Brain, 118(3), 707-719. DOI: 10.1093/brain/118.3.707 
Held, A., Major, P., Sahin, A., Reenan, R.A., Lipscombe, D., & Wharton, K.A. (2019). Circuit  
dysfunction in SOD1-ALS model first detected in sensory feedback prior to motor neuron  
degeneration is alleviated by BMP signaling. The Journal of neuroscience, 39(12), 2347- 
2364. doi: 10.1523/JNEUROSCI.1771-18.2019  
Holzbaur, E.L., & Tokito, M.K. (1995). Localization of the DCTN1 gene encoding p150Glued to  
human chromosome 2p13 by Fluorescence in situ hybridization. Genomics, 31(3), 398- 
399. doi: 10.1006/geno.1996.0068 
Hwang, I., Kim, C.K., Ko, H.R., Park, K.W., Cho, S.W., & Ahn, J.Y. (2016). C-terminal domain  
of p42 Ebp1 is essential for down regulation of p85 subunit of PI3K, inhibiting tumor  
growth. Science Reports, 6, 30626. doi: 10.1038/srep30626  
Jaarsma D., Haasdijk, E.D., Grashorn, J.A., Hawkins, R., Van Dujin, W., Verspaget, H.W., … &  
Holstege, J.C. (2000). Human Cu/Zn superoxide dismutase (SOD1) overexpression in  
mice causes mitochondrial vacuolization, axonal degeneration, and premature  
motoneuron death and accelerates motoneuron disease in mice expressing a familial  
amyotrophic lateral sclerosis mutant SOD1. Neurobiology of disease, 7(6 Pt B), 623-643.  
doi: 10.1006/nbdi.2000.0299 
Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., … & Zipursky, S.L.  
44 
 
(1998). Polyglutamine-expanded human huntingtin transgenes induce degeneration of  
Drosophila photoreceptor neurons. Neuron, 21(3), 633-642. doi: 10.1016/s0896- 
6273(00)80573-5 
Johnston, J.A., Dalton, M.J., Gurney, M.E., & Kopito, R.R. (2000). Formation of high molecular  
weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial  
amyotrophic lateral sclerosis. PNAS, 97(23), 12571-12576. Doi:  
10.1073/pnas.220417997 
Kawahara, Y., & Mieda-Sato, A. (2012). TDP-43 promotes microRNA biogenesis as a  
component of the Drosha and Dicer complexes. PNAS, 109(9), 3347-3352. doi:  
10.1073/pnas.1112427109 
Kerman, A., Liu, H.N., Croul, S., Bilbao, J., Rogaeva, E., Zinman, L., … & Chakrabartty, A.  
(2010). Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive  
misfolding of SOD1 is unique to the familial form. Acta Neuropathologica, 119(3), 335- 
344. doi: 10.1007/s00401-010-0646-5 
Khare, S.D., Caplow, M., & Dokholyan N.V. (2004). The rate and equilibrium constants for  
multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic  
lateral sclerosis. PNAS, 104(42), 15094-15099. doi: 10.1073/pnas.0406650101 
Lalmansingh, A.S., Urekar, C.J., & Reddi, P.P. (2011). TDP-43 is a transcriptional repressor: the  
testis-specific mouse acrv1 gene is a TDP-43 target in vivo. Journal of Biological  
Chemistry, 286(13), 10970-10982. doi: 10.1074/jbc.M110.166587 
Lee, H., Radu, C., Han, J.W., & Grailhe, R. (2017). Assay development for high content  
quantification of Sod1 mutant protein aggregate formation in living cells. Journal of  
Visualized Experiments, 128, 56425. doi: 10.3791/56425 
45 
 
Lee, S.B., Kim, W., Lee, S., & Chung, J. (2007). Loss of LRRK2/PARK8 induces degeneration  
of dopaminergic neurons in Drosophila. Biochemical and biophysical research  
ecommunications, 358(2), 534-539. doi: 10.1016/j.bbrc.2007.04.156  
Leigh, P.N., Whitwell, H., Garofalo, O., Buller, J., Swash, M., Martin, J.E., … & Anderton, B.H.  
(1991). Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral  
sclerosis. Morphology, distribution, and specificity. Brain, 114(2), 775-788. doi:  
10.1093/brain/114.2.775 
Liu, H.N., Sanelli, T., Horne, P., Pioro, E.P., Strong, M.J., Rogaeva, E., … & Robertson, J.  
(2009). Lack of evidence of monomer/misfolded, superoxide dismutase-1 in sporadic  
amyotrophic lateral sclerosis. Annals of Neurology, 66(1), 75-80. doi: 10.1002/ana.21704 
Martins, D., & English, A.M. (2014). SOD1 oxidation and formation of soluble aggregates in  
yeast: Relevance to sporadic ALS development. Redox Biology, 2, 632-639. doi:  
10.1016/j.redox.2014.03.005 
Mather, K., Martin, J.E., Swash, M., Vowles, G., Brown, A., & Leigh, P.N. (1993).  
Histochemical and immunocytochemical study of ubiquitinated neuronal inclusions in  
amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology, 19(2) 141-145.  
doi: 10.1111/j.1365-2990.1993.tb00419.x 
Matsumoto, G., Aleksandar, S., Holmberg, C.I., Kim, S., Morimoto, R.I. (2005). Structural  
properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn  
superoxide dismutase 1 aggregates. Journal of Cell Biology, 171(1), 75-85. doi:  
10.1083/jcb.200504050  
Matsumoto, S., Kusaka, H., Ito, H., Shibata, N., Asayama, T., & Imai, T. (1996). Sporadic  
amyotrophic lateral sclerosis with dementia and Cu/Zn superoxide dismutase-positive  
46 
 
Lewy body-like inclusions. Clinical neuropathology, 15(1), 41-46.  
Mayeux, V., Corcia, P., Besson, G., Jafari-Schluep H.F., Briolotti, V., & Camu, W. (2003).  
N19S, a new SOD1 mutation in sporadic amyotrophic lateral sclerosis: no evidence for  
disease causation. Annals of neurology, 53(6), 815-818. doi: 10.1002/ana.10605 
McAlary, L., Aquilina, J.A., & Yerbury, J.J. (2016). Susceptibility of mutant SOD1 to form a  
destabilized monomer predicts cellular aggregation and toxicity but not in vitro  
aggregation propensity. Frontiers in Neuroscience, 10, 499. doi:  
10.2289/fnins.2016.00499  
Medinas, D.B., Rozas, P., Traub, F.M., Woehlbier, U., Brown, R.H., Bosco, D.A., & Hetz, C.  
(2018). Endoplasmic reticulum stress leads to accumulation of wild-type SOD1  
aggregates associated with sporadic amyotrophic lateral sclerosis. PNAS, 115(32), 8209- 
8214. doi: 10.1073/pnas.1801109115 
Morgan, T.H. (1910). Sex limited inheritance in Drosophila. Science, 32(812), 120-122. doi:  
10.1126/science.32.812.120  
Münch, C., & Bertolotti, A. (2010). Exposure of hydrophobic surfaces initiates aggregation of  
diverse ALS-causing superoxide dismutase-1 mutants. Journal of Molecular Biology,  
399(3), 515-525. doi: 10.1016/jmb.2010.04.019 
Münch, C., Sedlmeier, R., Meyer, T., Homber, V., Sperfeld, A.D., Kurt, A., … & Ludoph, A.C.  
(2004). Point mutations of the p150 subunit of dyactin (DCTN1) gene in ALS.  
Neurology, 63(4), 724-726. doi: 10.1212/01.wnl.0000134608.83927.b1 
Nassif, M., Valenzuela, V., Rojas-Rivera, D., Vidal, R., Matus, S., Castillo, K., … & Hetz, C.  
(2014). Pathogenic role of BENC1/Beclin 1 in the development of amyotrophic lateral  
sclerosis. Autophagy, 10(7), 1256-1271. doi: 10.4161/auto.28784  
47 
 
NCBI (2020, March 13). PA2G4 proliferation-associated 2G4 [Homo sapiens (human)].  
https://www.ncbi.nlm.nih.gov/gene/5036 
Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., … Lee,  
V.M. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and  
amyotrophic lateral sclerosis. Science, 314(5796), 130-133. doi:  
10.1126/science.1134108 
Nguyen, X.T., Zhu, L., Lee, Y., Ta, L., & Mitchell, B.S. (2016). Expression and role of the  
ErbB3-binding protein 1 in Acute Myelogenous Leukemic Cells. Clinical Cancer  
Research, 22(13), 3320-3327. doi: 10.1158/1078-0432.CCR-15-2282 
Okamoto, K., Kihira, T., Kondo, T., Kobashi, G., Washio, M., Sasaki, S., … & Nagai, M.  
(2007). Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotrophic  
lateral sclerosis, 8(5), 300-304. doi: 10.1080/17482960701472249 
Pan, K.M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., … & Cohen, F.E.  
(1993). Conversion of alpha-helices into beta-sheets features in the formation of the  
scrapie prion proteins. PNAS, 90(23), 1096210966. doi: 10.1073/pnas.90.23.10962 
Paré, B., Lehmann, M., Beaudin, M., Nordström, U., Saikali, S., Julien, J.P., … & Gros-Louis, F.  
(2018). Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Scientific  
Reports, 8(1), 14223. doi: 10.1038/s41598-01831773-z 
Pasinelli, P., & Brown, R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights  
from genetics. Nature Reviews Neuroscience, 7(9), 710-723. doi: 10.1038/nrn1971 
Prudencio, M., & Borchelt, D.R. (2011). Superoxide dismutase 1 encoding mutations linked to  
ALS adopt a spectrum of misfolded states. Molecular neurodegeneration, 66, 77. doi:  
10.1186/1750-1326-6-77   
48 
 
Rakhit, R., Crow, J.P., Lepock, J.R., Kondejewski, L.H., Cashman, N.R., & Chakrabartty, A.  
(2004). Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in  
the oxidation models of sporadic and familial amyotrophic lateral sclerosis. The Journal  
of Biological Chemistry, 279(15), 15499-15504. doi: 10.1074/jbc.M313295200 
Ramesh, N., & Pandey, U.B. (2017). Autophagy dysregulation in ALS: when protein aggregates  
get out of hand. Frontiers in Molecular Neuroscience, 10, 263. doi:  
10.3389/fnmole.2017.00263 
Reaume, A.G., Elliot, J.L., Hoffman, E.K., Kowall, N.W., Ferrante, R.J., Siwek, D.F., … &  
Snider, W.D. (1996). Motor neurons in Cu/Zn, superoxide dismutase-deficient mice  
develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics,  
13(1), 43-47. doi: 10.1038/ng0596-43 
Rosen, D.R., Siddique, T. Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., … & Brown,  
R.H. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial  
amyotrophic lateral sclerosis. Nature, 362(6415), 59–62. doi: 10.1038/362059a0  
Saccon, R.A., Bunton-Stasyshyn, R.K, Fisher, E.M., & Fratta, P. (2013). Is SOD1 loss of  
function involved in amyotrophic lateral sclerosis? Brain, 136(Pt 8), 2342-2358. doi:  
10.1093/brain/awt097   
Şahin, A., Held, A., Bredvik, K., Major, P., Achilli, T.M., Kerson, A.G., … & Reenan, R.A.  
(2017). Human SOD1 ALS mutations in a Drosophila knock-in model cause severe  
phenotypes and reveal dosage-sensitive gain- and loss-of-function components. Genetics,  
205(2), 707-723. doi: 10.1534/genetics.116.190850  
Sangwan, S., Zhao, A., Adams, K.L., Jayson, C.K., Sawaya, M.R., Guenther, E.L., … &  
Eisenberg, D.S. (2017). Atomic structure of toxic, oligomeric segment of SOD1 linked to  
49 
 
amyotrophic lateral sclerosis (ALS). PNAS, 114(33), 8770-8775. doi:  
10.1073/pnas.1705091114 
Sea, K., Sohn, S.H., Durazo, A., Sheng, Y., Shaw, B.F., Cao, X., … & Valentine, J.S. (2015).  
Insights into the role of the unusual disulfide bond in coper-zinc superoxide dismutase.  
Journal of Biological Chemistry, 290(4), 2405-2418. doi: 10.1074/jbc.M114.588798 
Shibata, N., Asayama, K., Hirano, A., & Kobayashi, M. (1996). Immunohistochemical study on  
superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral  
sclerosis. Developmental Neuroscience, 18(5-6), 492-498. doi: 10.1159/000111445 
Shibata, N., Hirano, A., Kobayashi, M., Sasaki, S., Kato, T., Matsumoto, S., … & Asayama, K.  
(1994). CuZn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions  
of sporadic amyotrophic lateral sclerosis. Neuroscience letters, 179(1-2), 149-152. doi:  
10.1016/0304-3940(94)90956-3  
Sturtz L.A., Diekert, K., Jensen, L.T., Lill, R., & Culotta V.C. (2001). A fraction of yeast Cu,Zn- 
superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane  
space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial  
oxidative damage. The Journal of Biological Chemistry, 276(41), 38084-38089. doi:  
10.1074/jbc.M105296200 
Tokuda, E., Brännström, T., Andersen, P.M., & Marklund, S.L. (2016). Low autophagy capacity  
implicated in motor system vulnerability to mutant superoxide dismutase. Acta 
neuropathologica communications, 25, 4-6. doi: 10.1186/s40478-016-0274-y 
Tsang, C.K., Liu, Y., Thomas, J., Zhang, Y., & Zheng, X.F. (2014). Superoxide dismutase 1 acts  
as a nuclear transcription factor to regulate oxidative stress resistance. Nature  
Communications, 5, 3446. doi: 10.1038/ncomms4446 
50 
 
Vlab Amrita Edu. (2012). Counting of Total Fluorescence in a Cell. Virtual Amrita Laboratories  
Universalizing Education. Retrieved 20 November 2018, from 
vlab.amrita.edu/?sub=3&brch=278&sim=1474&cnt=2 
Wang, L., Deng, H.X., Grisotti, G., Zhai, H., Siddique, T., & Roos, R.P. (2009). Wild-type  
SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse. Human  
Molecular Genetics, 18(9), 1642-1651. doi: 10.1093/hmg/ddp085 
Wang, X.D., Zhu, M.W., Shan, D., Wang, S.Y., Yin, X., Yang, Y.Q., … & Feng, H.L. (2019).  
Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in  
response to mutant SOD1-induced DNA damage. DNA Repair, 74, 51-62. doi:  
10.1016/j.dnarep.2018.12.005 
Wong, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N.G., Jenkins, N.A., … & Price,  
D.L. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor  
neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14(6),  
1105-1116. doi: 10.1016/0896-6273(95)09259-7 
Xie, Y., Zhou, B., Lin, M.Y., Wang, S., Foust, K.D., & Sheng, Z.H. (2015). Endolysosomal  
deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS  
mice. Neuron, 87(2), 355-370. doi: 10.1016/j.neuron.2015.06.026 
Zhang, Y., Lu, Y., Zhou, H., Lee, M., Liu, Z., Hassel, B.A., & Hamburger, A.W. (2008).  
Alterations in cell grouth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice.  
BMC cell biology, 9, 69. doi: 10.1186/1471-2121-9-69 
Zhang, K., Shi, P., An, T., Wang, Q., Wang, J., Li, Z., … & Guo, Y. (2013). Food restriction- 
induced autophagy modulates degradation of mutant SOD1 in an amyotrophic lateral  
sclerosis mouse model. Brain research, 1519, 112-119. doi:  
51 
 
10.1016/j.brainres.2013.04.050    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
FIGURES   
             
            
53 
 
Figure 1. Aggregate-specific antibody 56-71 detected large cytoplasmic aggregates in 
dsod1G85R/G85R and dsod1H48R/H48R salivary glands at partial penetrance. dSOD1 aggregates 
are localized around the nucleus in dsod1G85R/G85R samples with partial penetrance (white arrows) 
and diffuse large cytoplasmic aggregates were detected in dsod1H48R/H48R samples also with 
partial penetrance. A. Single slice images of wandering dsod1-/-, dsod1+/+, dsod1H48R/H48R, and 
dsod1G85R/G85R larvae salivary glands stained with the aggregate specific 56-71 antibody at 1:300 
(except dsod1H48R/H48R which was stained at 1:100). DAPI (1:1000); AlexaFluor 647 (1:400). B. 
Average CTCF quantifications for the cytoplasm and nucleus of each line for all samples except 
dsod1G85R (B). Error bars represent standard error.  
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Figure 2. Aggregate-specific antibody 111-126 detected large cytoplasmic aggregates in 
dsod1H48R/H48R salivary glands at partial penetrance. A. Single slice confocal images of 
wandering dsod1-/-, dsod1+/+, and dsod1H48R/H48R larvae salivary glands stained with the 
aggregate-specific 111-126 antibody at 1:500. DAPI (1:1000); AlexaFluor 647 (1:400). B. 
Average CTCF for the cytoplasm and nucleus of each line. Bars represent standard error. C. The 
number of inclusions detected over a specific pixel intensity threshold (see methods). Error bars 
represent standard error. 
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Figure 3. dSOD1 shows stage-specific aggregation. Time course analysis of dsod1+/+ and 
dsod1H48R/H48R salivary glands at third instar, wandering, and pre-pupation stages stained with 
two aggregate specific antibodies. Salivary glands were incubated in aggregate-specific 
antibodies at concentrations ranging from 1:100 to 1:300. Single slice confocal images were 
processed using ImageJ software. DAPI (1:1000); AlexaFluor 647 (1:400). 3rd = third-instar; W 
= wandering; PP = pre-pupation.  
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Figure 4. Mutant salivary glands are morphologically comparable to wildtype samples 8 
hours post-pupation. Time course analysis of dsod1-/-, dsod1+/+, dsod1G85R/G85R, and 
dsod1H48R/H48R salivary glands at pre-pupation or 8 hours post-pupation stages. Salivary glands 
were incubated in the aggregate-specific antibody 111-126 at 1:300. DAPI (1:1000); AlexaFluor 
647 (1:400). Single slice confocal images were processed using ImageJ software is presented. A. 
Pre-pupation stage. B. 8 hours post-pupation.  
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Figure 5. dsod1-/- had the largest vacuoles and dsod1G85R/G85R had the shortest compared to 
all other lines. A. Single slice confocal images of highly vacuolized dsod1-/-, dsod1+/+, 
dsod1G85R/G85R, and dsod1H48R/H48R salivary glands 8 hours post-pupation were incubated in the 
aggregate-specific 111-126 antibody at 1:300. All images were processed using ImageJ. DAPI 
(1:1000); AlexaFluor 647 (1:400). B. Average length of vacuoles. The longest length of ten 
vacuoles in each sample was measured using ImageJ and all measurements were averaged on 
excel. Error bars represent standard error. 
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Figure 6. dsod1G85R/G85R, and dsod1H48R/H48R VNCs display mutant-specific differences 
compared to null and wildtype. Ventral nerve cords (VNC) of dsod1H48R/H48R pharate adults 
displayed large aggregates that colocalized with large nuclei, and the dsod1G85R/G85R had dense 
staining compared to null and wildtype. VNCs of dsod1-/-, dsod1+/+, dsod1G85R/G85R, and 
dsod1H48R/H48R pharate adults were incubated in the aggregate-specific 56-71 antibody. dsod1-/- 
and dsod1G85R/G85R 56-71 staining was at 1:1000; dsod1+/+and dsod1H48R/H48R 56-71 staining was 
at 1:500. DAPI (1:1000); AlexaFluor 647 (1:800). Single slice confocal images were corrected 
on ImageJ.  
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Figure 7. Preliminary data suggests ebp1 knockdown increases dSOD1 selectively in 
dsod1G85R/+ heterozygotes. A. Wandering stage larvae salivary glands of dsod1-/-, dsod1G85R/+, 
and ebp1RNAi;dsod1G85R/+ reared on fly food containing 0 μL/mL or 3μL/mL of MIF were 
collected and incubated in aggregate-specific antibody 56-71 at 1:300. Single slice confocal 
images were analyzed using ImageJ. DAPI (1:1000); AlexaFluor 647 (1:400). B. Average CTCF 
for nuclear and cytoplasmic dSOD1 staining for each dsod1 line. Error bars represent standard 
error. 
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Table 1. Partial penetrance of mutant dsod1G85R/G85R and dsod1H48R/H48R phenotype among a 
collection of individual confocal images. 
 
 
